Beam Therapeutics Inc. (BEAM)

BEAM trades at $25.75, 28.7% above the near-term max pain of $20 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($16-$21), reflecting growing call interest at higher strikes. Key magnetic zone at 20 where 5 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for BEAM shows an upward trend from 16 to 21, suggesting bullish positioning in longer-dated options. The 26% spread signals divergent expectations across timeframes. Most levels below 25.75 may cap rallies. Strong magnetic level at 20 (5 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.